BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15963213)

  • 1. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
    Cowie MR
    Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
    Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
    Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
    Frishman WH; Zuckerman AL
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
    Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
    Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.
    Zamorano J; Erdine S; Lopez AP; Kim JH; Al Khadra A; Westergaard M; Sutradhar S; Yunis C;
    Postgrad Med; 2010 Mar; 122(2):7-15. PubMed ID: 20203451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial.
    Zamorano J; Erdine S; Pavia A; Kim JH; Al-Khadra A; Westergaard M; Sutradhar S; Yunis C;
    Curr Med Res Opin; 2011 Apr; 27(4):821-33. PubMed ID: 21306285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
    Blank R; Hobbs FD; Zamorano J; Girerd X
    Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.
    Flack JM; Victor R; Watson K; Ferdinand KC; Saunders E; Tarasenko L; Jamieson MJ; Shi H; Bruschi P
    Mayo Clin Proc; 2008 Jan; 83(1):35-45. PubMed ID: 18174006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
    McKeage K; Siddiqui MA
    Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-pill combination of amlodipine besylate and atorvastatin calcium.
    Blank R
    Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP
    Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
    Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):835-43. PubMed ID: 20528641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study).
    Blank R; LaSalle J; Reeves R; Maroni J; Tarasenko L; Sun F
    J Clin Hypertens (Greenwich); 2005 May; 7(5):264-73. PubMed ID: 15886529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
    Delgado-Montero A; Zamorano JL
    Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.